In this conversation, Candid Capital. and Martin Cheski discuss the landscape of venture capital, focusing on TELUS Global Ventures' investment strategies, market trends, and the role of AI in the industry. They explore the differences between Canadian and global markets, provide advice for emerging fund managers, and commentary on EBITDA in Venture. The discussion also highlights the growing importance of corporate venture capital and its impact on innovation. In this conversation, Martin Cheski discusses the strategic approach of TGV in venture capital, emphasizing the importance of curated partnerships and collaboration with other investors. He highlights the unique dynamics between corporate venture capital and startups, and shares insights on successful portfolio companies like FirstVet and Kode Labs. The discussion also delves into innovative healthcare solutions, including Q Labs and Q Bio, and the future of personalized medicine with GenXys, showcasing how technology is transforming the healthcare landscape.

Chapters

00:00 Introduction to Talis Global Ventures

02:52 Investment Focus and Thematic Areas

06:11 Market Trends and VC Landscape

09:07 AI's Role in Venture Capital

12:11 Comparative Analysis of Canadian and Global Markets

15:01 Advice for Emerging Fund Managers

17:53 Understanding EBITDA in Venture Capital

21:53 Corporate Venture Capital Insights

29:08 Strategic Partnerships in Venture Capital

30:45 Corporate Venture Capital: A Multi-Pronged Approach

33:23 Navigating the Founder-Corporate Relationship

35:40 Showcasing Portfolio Success: FirstVet and Code Labs

43:21 Innovations in Healthcare: Q Labs and Q Bio

49:53 The Future of Personalized Medicine: GeneXus